Holley Inc.
HLLY NYSE Motor Vehicle Parts & Accessories Financials FY2019βFY2025
What Holley Inc. does
No business description yet.
- Legal name
- Holley Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 16, 2026
- Accession Β· CIK
- 0001628280-26-018218
0001822928
Revenue and margins
Holley Inc. had $614M of revenue in fiscal 2025, up 1.9% on the year before.
Net income and earnings per share
From fiscal 2019 to 2025, diluted EPS grew 58.7% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $33.9M in fiscal 2025, 5.5% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Holley Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 1.4%.
Balance sheet
Cash, debt and the ratios that show how comfortably Holley Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $36.3M | $26.2M | $41.1M | $56.1M | $37.2M |
| Debt incl. finance leases | $646M | $651M | $584M | $553M | $523M |
| Net debt / EBITDA | 6.8x | 10.3x | 5.2x | 19.7x | 5.3x |
| Debt / equity | 2.1x | 1.6x | 1.3x | 1.3x | 1.2x |
| Interest coverage | 2.0x | 1.3x | 1.5x | 0.3x | 1.6x |
| Current ratio | 3.2x | 3.2x | 3.2x | 3.1x | 2.7x |
| Quick ratio | 1.2x | 0.9x | 1.1x | 1.1x | 1.0x |
| Total assets | $1.2B | $1.2B | $1.2B | $1.1B | $1.2B |
| Total liabilities | $889M | $834M | $762M | $712M | $715M |
| Shareholders' equity | $304M | $416M | $441M | $421M | $449M |
| Net debt (β = net cash) | $609M | $624M | $543M | $496M | $486M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β |
| F-score | β / 3 | β / 5 | 6 / 9 | 5 / 9 | 5 / 9 | 4 / 9 | 6 / 9 |
| Accruals ratio | β | β5.2% | β4.3% | 5.0% | β5.6% | β6.0% | β2.4% |
| Altman Z'' | β | 1.94 | 1.83 | 2.10 | 2.43 | 2.01 | 2.45 |
7 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | $369M | $504M | $693M | $688M | $660M | $602M | $614M |
| Gross profit | $149M | $208M | $287M | $254M | $256M | $239M | $266M |
| Research and development | $20.6M | $23.5M | $28.3M | $29.1M | $23.8M | $18.7M | $18.8M |
| Operating income | $46.1M | $85.5M | $77.5M | $50.7M | $94.0M | $14.7M | $82.5M |
| Interest expense | $50.4M | $43.8M | $39.1M | $40.2M | $60.7M | $50.7M | $51.8M |
| Pretax income | β$4.3M | $41.7M | β$16.7M | $78.3M | $27.6M | β$26.3M | $28.6M |
| Income tax | β$4.9M | $8.8M | $10.4M | $4.5M | $8.4M | β$3.0M | $9.5M |
| Net income | $0.6M | $32.9M | β$27.1M | $73.8M | $19.2M | β$23.2M | $19.2M |
| Net income to common | β | $32.9M | β$27.1M | $73.8M | $19.2M | β$23.2M | β |
| Diluted EPS | $0.01 | $0.49 | β$0.30 | $0.14 | $0.16 | β$0.20 | $0.16 |
| Diluted shares | 0.07B | 0.07B | 0.09B | 0.12B | 0.12B | 0.12B | 0.12B |
| Cash flow | |||||||
| Cash from operations | $9.4M | $88.4M | $21.6M | $12.3M | $88.1M | $46.9M | $46.2M |
| Capital expenditure | $7.4M | $9.4M | $15.2M | $13.6M | $5.9M | $6.8M | $12.3M |
| Free cash flow | $2.0M | $79.0M | $6.4M | β$1.3M | $82.2M | $40.1M | $33.9M |
| Depreciation and amortization | $8.8M | $7.9M | $11.5M | $10.1M | $10.3M | $10.6M | $9.7M |
| Stock-based compensation | $0.4M | $0.5M | $5.0M | β | β | β | β |
| Acquisitions | $5.9M | $157M | $119M | $14.3M | $0.0M | $0.0M | β |
| Balance sheet | |||||||
| Cash and short-term investments | $8.3M | $71.7M | $36.3M | $26.2M | $41.1M | $56.1M | $37.2M |
| Total debt | β | $655M | $646M | $651M | $584M | $553M | $523M |
| Finance lease liabilities | β | β | β | β | β | $0.0M | $0.2M |
| Current assets | β | $258M | $292M | $325M | $297M | $297M | $316M |
| Current liabilities | β | $82.0M | $91.8M | $101M | $93.7M | $95.2M | $115M |
| Inventory | β | $134M | $185M | $234M | $192M | $193M | $206M |
| Property and equipment, net | β | $43.7M | $51.5M | $52.2M | $47.2M | $41.0M | $45.1M |
| Goodwill | $298M | $359M | $411M | $418M | $419M | $372M | $372M |
| Intangible assets | β | $405M | $438M | $425M | $410M | $387M | $397M |
| Total assets | β | $1.1B | $1.2B | $1.2B | $1.2B | $1.1B | $1.2B |
| Total liabilities | β | $825M | $889M | $834M | $762M | $712M | $715M |
| Preferred stock | β | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $205M | $240M | $304M | $416M | $441M | $421M | $449M |
| Margins | |||||||
| Gross margin | 40.4% | 41.3% | 41.4% | 36.8% | 38.8% | 39.6% | 43.4% |
| Operating margin | 12.5% | 16.9% | 11.2% | 7.4% | 14.3% | 2.4% | 13.4% |
| EBITDA margin | 14.9% | 18.5% | 12.9% | 8.8% | 15.8% | 4.2% | 15.0% |
| Net margin | 0.2% | 6.5% | β3.9% | 10.7% | 2.9% | β3.9% | 3.1% |
| FCF margin | 0.5% | 15.7% | 0.9% | β0.2% | 12.5% | 6.7% | 5.5% |
| Returns | |||||||
| Return on capital | β | 8.2% | 6.7% | 4.6% | 6.6% | 1.3% | 5.9% |
| Return on capital employed | β | 8.7% | 7.0% | 4.4% | 8.5% | 1.4% | 7.9% |
| Return on equity | 0.3% | 14.7% | β10.0% | 20.5% | 4.5% | β5.4% | 4.4% |
| Return on assets | β | 3.1% | β2.4% | 6.0% | 1.6% | β2.0% | 1.7% |
| Growth | |||||||
| Revenue growth | β | 36.8% | 37.4% | β0.6% | β4.2% | β8.7% | 1.9% |
| Net income growth | β | 5,756.9% | β182.6% | β | β74.0% | β221.1% | β |
| EPS growth | β | 4,800.0% | β161.2% | β | 14.3% | β225.0% | β |
| FCF growth | β | 3,854.9% | β92.0% | β120.1% | β | β51.2% | β15.5% |
| Share count change | β | 0.0% | 32.9% | 30.3% | 1.1% | β0.1% | 1.4% |
| Financial health | |||||||
| Net debt / EBITDA | β | 6.2x | 6.8x | 10.3x | 5.2x | 19.7x | 5.3x |
| Debt / equity | β | 2.7x | 2.1x | 1.6x | 1.3x | 1.3x | 1.2x |
| Interest coverage | 0.9x | 2.0x | 2.0x | 1.3x | 1.5x | 0.3x | 1.6x |
| Current ratio | β | 3.1x | 3.2x | 3.2x | 3.2x | 3.1x | 2.7x |
| Quick ratio | β | 1.5x | 1.2x | 0.9x | 1.1x | 1.1x | 1.0x |
| Capital allocation | |||||||
| Capex / revenue | 2.0% | 1.9% | 2.2% | 2.0% | 0.9% | 1.1% | 2.0% |
| Stock comp / revenue | 0.1% | 0.1% | 0.7% | β | β | β | β |
| Quality scores | |||||||
| Piotroski F-score | β | β | 6.0 | 5.0 | 5.0 | 4.0 | 6.0 |
| Altman Z'' | β | 1.9 | 1.8 | 2.1 | 2.4 | 2.0 | 2.4 |
| Accruals ratio | β | β5.2% | β4.3% | 5.0% | β5.6% | β6.0% | β2.4% |
Source: SEC EDGAR XBRL filings (CIK 0001822928). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.